Financhill
Sell
14

NNOX Quote, Financials, Valuation and Earnings

Last price:
$2.15
Seasonality move :
-14.06%
Day range:
$2.22 - $2.43
52-week range:
$2.22 - $7.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.49x
P/B ratio:
0.93x
Volume:
1.2M
Avg. volume:
1.2M
1-year change:
-67.86%
Market cap:
$146.5M
Revenue:
$11.3M
EPS (TTM):
-$0.88

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NNOX
Nano-X Imaging Ltd.
$4M -$0.15 33.13% -35.84% $7.40
ICCM
IceCure Medical Ltd.
$1.3M -$0.04 196.97% -49.43% $3.13
LAB
Standard BioTools, Inc.
$18.5M -$0.03 -54.41% -72.53% $1.55
LUDG
Ludwig Enterprises, Inc.
-- -- -- -- --
XYLO
Xylo Technologies Ltd.
-- -- -- -- $9.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NNOX
Nano-X Imaging Ltd.
$2.24 $7.40 $146.5M -- $0.00 0% 11.49x
ICCM
IceCure Medical Ltd.
$0.59 $3.13 $40.8M -- $0.00 0% 11.95x
LAB
Standard BioTools, Inc.
$1.19 $1.55 $457.6M -- $0.00 0% 3.50x
LUDG
Ludwig Enterprises, Inc.
$0.0220 -- $3.6M -- $0.00 0% 36,962.14x
XYLO
Xylo Technologies Ltd.
$5.07 $9.00 $6.5M -- $3.94 0% 0.13x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NNOX
Nano-X Imaging Ltd.
4.79% 1.591 3.26% 3.82x
ICCM
IceCure Medical Ltd.
3% -0.652 0.41% 1.76x
LAB
Standard BioTools, Inc.
6.41% 0.841 5.49% 1.93x
LUDG
Ludwig Enterprises, Inc.
-144.65% -0.654 24.05% 0.00x
XYLO
Xylo Technologies Ltd.
29.91% -1.122 154.75% 0.95x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NNOX
Nano-X Imaging Ltd.
-$3M -$14.2M -31.33% -32.75% -412.88% -$13.9M
ICCM
IceCure Medical Ltd.
$277K -$3.8M -195.32% -217.45% -451.29% -$3.1M
LAB
Standard BioTools, Inc.
$9.5M -$23.5M -22.34% -24.44% -120.02% -$23.1M
LUDG
Ludwig Enterprises, Inc.
-- -$371.4K -- -- -419868.12% -$139.1K
XYLO
Xylo Technologies Ltd.
-- -- -40.15% -51.7% -- --

Nano-X Imaging Ltd. vs. Competitors

  • Which has Higher Returns NNOX or ICCM?

    IceCure Medical Ltd. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -454%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat IceCure Medical Ltd.'s return on equity of -217.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    ICCM
    IceCure Medical Ltd.
    32.59% -$0.06 $9.6M
  • What do Analysts Say About NNOX or ICCM?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 230.36%. On the other hand IceCure Medical Ltd. has an analysts' consensus of $3.13 which suggests that it could grow by 428.68%. Given that IceCure Medical Ltd. has higher upside potential than Nano-X Imaging Ltd., analysts believe IceCure Medical Ltd. is more attractive than Nano-X Imaging Ltd..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    ICCM
    IceCure Medical Ltd.
    1 0 0
  • Is NNOX or ICCM More Risky?

    Nano-X Imaging Ltd. has a beta of 1.312, which suggesting that the stock is 31.211% more volatile than S&P 500. In comparison IceCure Medical Ltd. has a beta of 0.979, suggesting its less volatile than the S&P 500 by 2.136%.

  • Which is a Better Dividend Stock NNOX or ICCM?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IceCure Medical Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. IceCure Medical Ltd. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or ICCM?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than IceCure Medical Ltd. quarterly revenues of $850K. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than IceCure Medical Ltd.'s net income of -$3.9M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while IceCure Medical Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 11.49x versus 11.95x for IceCure Medical Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    11.49x -- $3.4M -$13.7M
    ICCM
    IceCure Medical Ltd.
    11.95x -- $850K -$3.9M
  • Which has Higher Returns NNOX or LAB?

    Standard BioTools, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -162.05%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Standard BioTools, Inc.'s return on equity of -24.44%.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    LAB
    Standard BioTools, Inc.
    48.51% -$0.09 $427M
  • What do Analysts Say About NNOX or LAB?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 230.36%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 30.25%. Given that Nano-X Imaging Ltd. has higher upside potential than Standard BioTools, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than Standard BioTools, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    LAB
    Standard BioTools, Inc.
    1 2 0
  • Is NNOX or LAB More Risky?

    Nano-X Imaging Ltd. has a beta of 1.312, which suggesting that the stock is 31.211% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.967%.

  • Which is a Better Dividend Stock NNOX or LAB?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or LAB?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Nano-X Imaging Ltd.'s net income of -$13.7M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 11.49x versus 3.50x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    11.49x -- $3.4M -$13.7M
    LAB
    Standard BioTools, Inc.
    3.50x -- $19.6M -$31.7M
  • Which has Higher Returns NNOX or LUDG?

    Ludwig Enterprises, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -427991.3%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Ludwig Enterprises, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    LUDG
    Ludwig Enterprises, Inc.
    -- -- -$1.4M
  • What do Analysts Say About NNOX or LUDG?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 230.36%. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Nano-X Imaging Ltd. has higher upside potential than Ludwig Enterprises, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than Ludwig Enterprises, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    LUDG
    Ludwig Enterprises, Inc.
    0 0 0
  • Is NNOX or LUDG More Risky?

    Nano-X Imaging Ltd. has a beta of 1.312, which suggesting that the stock is 31.211% more volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.470, suggesting its more volatile than the S&P 500 by 146.979%.

  • Which is a Better Dividend Stock NNOX or LUDG?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or LUDG?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Ludwig Enterprises, Inc. quarterly revenues of --. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 11.49x versus 36,962.14x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    11.49x -- $3.4M -$13.7M
    LUDG
    Ludwig Enterprises, Inc.
    36,962.14x -- -- $31.3K
  • Which has Higher Returns NNOX or XYLO?

    Xylo Technologies Ltd. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of --. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Xylo Technologies Ltd.'s return on equity of -51.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    XYLO
    Xylo Technologies Ltd.
    -- -- $22.4M
  • What do Analysts Say About NNOX or XYLO?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 230.36%. On the other hand Xylo Technologies Ltd. has an analysts' consensus of $9.00 which suggests that it could grow by 77.52%. Given that Nano-X Imaging Ltd. has higher upside potential than Xylo Technologies Ltd., analysts believe Nano-X Imaging Ltd. is more attractive than Xylo Technologies Ltd..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    XYLO
    Xylo Technologies Ltd.
    1 0 0
  • Is NNOX or XYLO More Risky?

    Nano-X Imaging Ltd. has a beta of 1.312, which suggesting that the stock is 31.211% more volatile than S&P 500. In comparison Xylo Technologies Ltd. has a beta of 0.321, suggesting its less volatile than the S&P 500 by 67.93%.

  • Which is a Better Dividend Stock NNOX or XYLO?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xylo Technologies Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $3.94 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Xylo Technologies Ltd. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or XYLO?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Xylo Technologies Ltd. quarterly revenues of --. Nano-X Imaging Ltd.'s net income of -$13.7M is higher than Xylo Technologies Ltd.'s net income of --. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Xylo Technologies Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 11.49x versus 0.13x for Xylo Technologies Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    11.49x -- $3.4M -$13.7M
    XYLO
    Xylo Technologies Ltd.
    0.13x -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
40
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
91
TDC alert for Feb 12

Teradata Corp. [TDC] is down 11.64% over the past day.

Buy
67
DIOD alert for Feb 12

Diodes, Inc. [DIOD] is down 7.63% over the past day.

Buy
77
VRT alert for Feb 12

Vertiv Holdings Co. [VRT] is down 4.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock